E. coli and Klebsiella spp. with resistance to carbapenem, year 2013

Slides:

Advertisements

Similar presentations

Massachusetts Department of Public Health

Advertisements

Antimicrobial resistance surveillance in Ireland Results of invasive Pseudomonas aeruginosa infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.

Antimicrobial resistance surveillance in Ireland Results of invasive Escherichia coli infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.

Aims of study This surveillance study was performed to determine the in vitro activity of ciprofloxacin against clinical isolates of Escherichia coli and.

Division of Public Health CRE Surveillance and Prevention of Transmission in Healthcare Settings Gwen Borlaug, CIC, MPH Coordinator, Healthcare-Associated.

Interpretation/Evaluation of Laboratory Data CLS 552 Human Microbiology & Immunology Laboratory Note: View this PowerPoint as a ‘Full Screen Slide Show’.

Resistance in Pseudomonas aeruginosa and Acinetobacter spp. from blood in the UK and Ireland Rosy Reynolds, Russell Hope, BSAC Working Party.

Hands on :1- How to find your article? 2- how to do a topic search Salima M’seffar INH- Bibliotheque

EARS-Net data on Antimicrobial Resistance in Ireland, Q3 2015

Antimicrobial resistance surveillance in Ireland Results of invasive Klebsiella pneumoniae infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.

The role of PHE’s AMRHAI Reference Unit Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit © Crown.

Multi-Resistant Gram Negative Microorganisms St Elisabeth Hospital Curacao.

Changing Epidemiology of Adult Bacterial Meningitis in Southern Taiwan: A Hospital-Based Study Infection 2008; 36: 15–22 W.-N. Chang, C.-H. Lu, C.-R. Huang,

D. Sauerwein International Journal of Antimicrobial Agents

Number of Colonized / Infected Patients with MRSA in Ontario

L.H. Su, T.L. Wu, C.H. Chiu Clinical Microbiology and Infection

Hire Toyota Innova in Delhi for Outstation Tour

E. coli and Klebsiella spp. with resistance to carbapenem, year 2011

Antibiotics sensitivity of microorganism causing nosocomial infections

Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli,

Spread of KPC-producing carbapenem-resistant Enterobacteriaceae: the importance of super-spreaders and rectal KPC concentration A. Lerner, A. Adler,

Changes to 10A NCAC 41A May 5, 2018.

C. Hauck, E. Cober, S. S. Richter, F. Perez, R. A. Salata, R. C

L. S. Tzouvelekis, A. Markogiannakis, E. Piperaki, M. Souli, G. L

L.H. Su, T.L. Wu, C.H. Chiu Clinical Microbiology and Infection

Molecular characterization of Echinococcus granulosus in south-eastern Romania: evidence of G1–G3 and G6–G10 complexes in humans L. Piccoli, C. Bazzocchi,

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

A simple laboratory algorithm for diagnosis of melioidosis in resource-constrained areas: a study from north-central Vietnam T.T. Trinh, T.S. Hoang,

Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome.

In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.

Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections D. Ben-David, R. Kordevani, N. Keller, I. Tal, A. Marzel, O. Gal-Mor, Y.

Quinolone resistance among Shigella spp

Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence.

Molecular characterization of Echinococcus granulosus in south-eastern Romania: evidence of G1–G3 and G6–G10 complexes in humans L. Piccoli, C. Bazzocchi,

Evaluation of differential gene expression in susceptible and resistant clinical isolates of Klebsiella pneumoniae by DNA microarray analysis A. Doménech-Sánchez,

The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents S. Brown, S.G.B. Amyes Clinical.

Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure Y.-C. Wang, Y.-T.

Characterizing non-linear effects of hospitalisation duration on antimicrobial resistance in respiratory isolates: an analysis of a prospective nationwide.

Potential risk factors for infection with Candida spp

Prevalence of Toscana virus antibodies in residents of Croatia

Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant.

A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals M. Nagao Clinical Microbiology and.

D.E. Low Clinical Microbiology and Infection

R. Cantón, M. Akóva, Y. Carmeli, C. G. Giske, Y. Glupczynski, M

The need for new antibiotics

The hidden killer: are we improving the management of bacteremia?

The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System M.E.A. de Kraker, V. Jarlier,

Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance D. van Duin, E.D. Cober, S.S. Richter,

E. coli and Klebsiella spp. with resistance to carbapenem, year 2009

Sofie Arens, Jan Verhaegen, Ludo Verbist

C. Peña, M.A. Dominguez, M. Pujol, R. Verdaguer, F. Gudiol, J. Ariza

Klebsiella pneumoniae resistant to third-generation cephalosporins in five African and two Vietnamese major towns: multiclonal population structure with.

Epidemiology of opportunistic infections in AIDS patients

Antibiotic resistance patterns of Escherichia coli isolates from different aquatic environmental sources in Leon, Nicaragua E. Amaya, D. Reyes, M. Paniagua,

Population structure analyses of Staphylococcus aureus at Tygerberg Hospital, South Africa, reveals a diverse population, a high prevalence of Panton–Valentine.

Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions M. Sjölund, S. Bengtsson, J. Bonnedahl,

W. -L. Yu, M. -F. Lee, H. -J. Tang, M. -C. Chang, J

Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant.

J. Garau Clinical Microbiology and Infection

New developments in laboratory monitoring of HIV-1 infection

Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases L. Romero, L. López,

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

C. Gagliotti, L. Nobilio, M.L. Moro

M. J. Medina-Pascual, S. Valdezate, G. Carrasco, P. Villalón, N

Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.

Diversity in VIM-2-encoding class 1 integrons and occasional blaSHV2a carriage in isolates of a persistent, multidrug-resistant Pseudomonas aeruginosa.

Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013 A. Badura, G. Feierl, G. Pregartner,

Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting A. Kronenberg, S. Koenig, S. Droz,

Abstracts accepted for publication only

Presentation transcript:

E. coli and Klebsiella spp. with resistance to carbapenem, year 2013 41/0 30/0 12/0 0/0 17/0 23/0 1/0 10/0 5/0 4/0 2/0 7/0 9/0 128/0 16/0 © FSO, ThemaKart - Neuchâtel 2006 Total: 310/0 This map summarizes the annual number of patients with isolation of E. coli or Klebsiella spp. with resistance to any carbapenem identified by Swiss clinical microbiology laboratories. The geographic distribution indicates the location of the microbiological laboratory and, for reasons of data protection, not the patient’s residence. The first number represents data collected in the ANRESIS database. The second number indicates cases reported actively to ANRESIS by clinical microbiology with reference activity for carbapenem resistance (last data query 05/2014). © anresis.ch, www.anresis.ch